Needs Finding

What commercializable issue is currently unresolved in the market, and who would want such a solution?

Problem Statement

Product Definition

Our product in development, meduCA, is a microbial biocementation platform that transforms waste substrates and CO₂ into hardened calcium carbonate - enabling dual use in mine tailing remediation on Earth and in-situ resource utilization (ISRU) for construction in space. On Earth, engineered microbes stabilize hazardous mine tailings by binding them into durable biocement, reducing reliance on conventional remediation methods, mitigating catastrophic risk, and lowering long-term liabilities. The process inherently consumes CO₂, which both validates biocement formation and provides the additional benefit of carbon sequestration. In space, the same system converts regolith and atmospheric CO₂ into strong building materials, enabling habitat construction and infrastructure development without heavy reliance on Earth-based supply chains. By integrating engineered organisms, mineral substrates, and CO₂, meduCA addresses hazardous material stabilization, remediation cost reduction, and resource scarcity, while providing scalable, sustainable infrastructure solutions both on Earth and beyond.


A diagram showing the different potential use cases of meduCA

Minimum Viable Product (MVP) Determination

Investors require assurances that the company they are investing in possess the requisite technical know-how and in-house expertise to deliver on the vision of the company. Here we will outline some of the quantifiable achievements that we believe will be sufficient to prove our capability to realize the Company’s vision.

Our Wet Lab team’s goal is to validate the core mechanism of Microbially-Induced Calcite Precipitation (MICP). We defined three MVP criteria:

  1. CO₂ Sequestration (Functional & Beneficial)
  1. Carbonic Anhydrase Surface Display Validation
  1. Material Output Characterization

Dry Lab

Our Dry Lab team is focused on production scale-up and structural deployment.

  1. Bioreactor Functionality
  1. 3D Bioprinter Production

Customer Profile

As stated in our Product Definition, we envision that our product will be applicable in two major use cases that can be broadly separated into terrestrial and extraterrestrial (Martian) use. These use cases differ significantly, and as a result, we separately identified stakeholders for each application.

Extraterrestrial (Martian) Application

Stakeholder Table


A diagram showing the interactions between stakeholder groups for the extraterrestrial application of meduCA

Detailed Explanation

We’ve segemented our stakeholders into six main categories to organize them according to common interests or capabilities. Stakeholders may belong to more than one category:

Pain and Gains


A diagram detailing the pains and gains of our solution to extraterrestrial stakeholders

Detailed Explanation

Earth Application

Stakeholder Table


A diagram showing the interactions between stakeholder groups for the terrestrial application of meduCA

Detailed Explanation

Jobs/Pains/Gains


A diagram detailing the pains and gains of our solution to terrestrial stakeholders

Detailed Explanation

Customer Segment Determination

To facilitate effective marketing and outreach to potential customers, we aggregated the potential stakeholders that may be potentially involved with the purchase and use of biocementation technologies into major segments according to common characteristics.

SegmentCustomer JobsPainsGains
Mining Companies (Earth)Stabilize tailings, reduce liability, ensure compliance, close sites safely.High remediation costs, tailings instability, long-term liabilities, carbon emissions, investor/ESG pressure.Lower remediation costs, reduced liabilities, carbon credits/offsets, potential for site repurposing, improved ESG/public perception.
Government Regulators & Agencies (Earth)Enforce remediation standards, certify closure, safeguard ecosystems.Difficult enforcement, inconsistent compliance, pressure from both industry and communities.Improved compliance, measurable sustainability progress, ecosystem protection, regulatory credibility, reduced fallout from disasters.
Remediation Contractors & Engineers (Earth)Deploy remediation technologies, design and execute closure plans, stabilize heterogeneous tailings.Technical challenges, high implementation costs, limited innovative options.Access to scalable, carbon-negative solutions with measurable stabilization, continuous containment, and adaptability to diverse sites.
Communities (Local & Indigenous, Earth)Advocate for safe reclamation, protect health and livelihoods, monitor impacts.Exposure to contaminated land/water, loss of trust in mining firms, limited decision power.Cleaner environments, lasting pollution reduction, reclaimed land for development, stronger role in decision-making, co-benefits from climate action.
Government Space Agencies (Space)Develop Martian infrastructure, support long-duration missions, comply with planetary protection policies.Harsh Martian conditions, high transport costs, strict policy frameworks.Reduced reliance on Earth logistics, credibility in sustainable missions, promotes international collaboration, self-sufficient ISRU infrastructure.
Space Companies (Space)Pioneer ISRU construction methods, unlock commercial opportunities.High R&D costs, legal uncertainties, unproven scaling of bio-based systems.First-mover advantage, licensing opportunities, industry partnerships.
Astronauts & Space Infrastructure Engineers (Space Users)Build and maintain extraterrestrial infrastructure with limited labor.Restricted manpower, dependency on fragile supply chains.Durable, automatable, locally produced building materials.
Future Settlers & Long-Term Projects (Space)Establish safe, sustainable habitats with minimal Earth resupply.Resource scarcity, vulnerability to harsh environmental extremes.Safer settlements, durable infrastructure, long-term sustainability.
Academic & Research Institutions (Earth & Space)Advance biocementation science, validate in extreme environments, cross-train future workforce.Limited funding, barriers to test environments, interdisciplinary gaps.Research platforms, funding/publication opportunities, academic credibility in biotech + space.